• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Starting with malaria diagnosis software, AHT looks for a breakthrough in blood diagnostics

Starting with malaria diagnosis software, AHT looks for a breakthrough in blood diagnostics

August 16, 2010 By MedCity News

MedCity News logo

A pre-revenue Ohio start-up could be on the way to creating a significant breakthrough in the blood diagnostics market, but it’ll be a little while before we know how likely American Health Technology Corp. is to get there.

The three-employee company developed technology that analyzes scanned blood samples and diagnoses whether the samples indicate diseases, such as leukemia and tuberculosis. The company’s software has the potential to boost the speed and accuracy of diagnosis, automating a process that often requires a heavy dose of human labor, according to Joe Borovsky, an entrepreneur who’s the New Albany, Ohio-based company’s president.

The first big test of the company‘s technology involves evaluating its ability to identify malaria parasites in blood samples. The “gold standard” for diagnosing malaria is the same as it was 100 years ago — a trained diagnostician examines samples under a microscope, said Roy Prescott, president of Hydas World Health a Hummelstown, Pennsylvania, nonprofit created to address the void in malaria diagnostics.

That’s risky because the process relies entirely on the skill of the scientist examining the samples. “The diagnostics have’t entered the 21st Century” when it comes to malaria, Prescott said.

Borovsky approached Prescott because Hydas has a large sample set of malaria slides that could be used to validate American Health’s technology. The Ohio company’s technology holds lots of potential — if it works as advertised, Prescott said. “If a computer can be trained to recognize the parasite in its myriad presentations … that would be very significant.”

In a cursory early test, the technology performed well enough to pique Prescott’s interest and make him eager to subject the software to a more formal, rigorous analysis, he said.

While malaria will provide an indication of the software’s capabilities, it isn’t necessarily where the short-term market potential lies. Analyzing samples from veterinary labs may wind up as the first commercial application of American Health’s software, Borovsky said.

The plan is to sign a deal with a major diagnostics company that analyzes samples sent by veterinarians, charging a per-sample fee. That arrangement would provide the diagnostics firm with cost savings as well as greater diagnostic accuracy, Borovsky said. He is in discussions with a few such companies, though he declined to provide names. “We only need one or two to say yes," he said.

In the meantime, the self-funded company has secured a state tax break for technology firms that figures to make it more attractive to Ohio-based investors. Borovsky would like to fund the company’s growth with revenues as long as he can. “At what point do you need that big investment to scale up?” he asked.

If the company’s technology shows enough promise, the answer may come sooner than later.

Filed Under: Business/Financial News, Diagnostics, News Well, Software / IT Tagged With: American Health Technology

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy